Neurological

A study has homed in on how aerobic exercise can improve memory in older subjects with cognitive impairment. The findings suggest it's never too late to start exercising as aerobic activity improves blood flow to parts of the brain linked to memory.

New research describes the successful results of animal studies testing a novel experimental peptide designed to inhibit the receptors responsible for chronic neuropathic pain. The research is now moving towards initial human trials.

Researchers have found that by subjecting people with a mild brain injury to a dose of blue light each morning, they could help to reduce some of its typical side effects such as depression and problems with sleep.

Two new studies are offering novel insights into celiac disease. One study is suggesting immune responses to gluten lead to neurological damage, while another offers hope for a cure demonstrating a nanoparticle treatment can induce immune tolerance.

New research has analyzed hundreds of brain scans from patients with schizophrenia revealing two distinct subtypes with differences in gray matter volumes, busting the previously held notion that all schizophrenia patients' brains are the same.

A paper is adding weight to the growing hypothesis suggesting the toxic protein clusters that cause Parkinson’s disease first aggregate in the gut before moving to the brain, and deficiency in a certain enzyme may help this mechanism.

A study has found an infusion of the naturally occurring hormone called kisspeptin can enhance brain activity related to sexual attraction in response to visual and odor cues. This suggests the hormone may be an effective treatment for low libido.

Scientists from McGill University are suggesting a novel microdose formulation of lithium could not only slow the progression of Alzheimer’s disease in its initial stages but potentially improve cognition at the early stages of decline.

A team of UK researchers has, for the first time in living human brains, demonstrated how the cognitive dysfunction seen in schizophrenia may be caused by the lack of a key protein known to facilitate communication between neurons in the brain.

A new study is describing how a particular probiotic bacterium may have the ability to prevent the abnormal accumulation of a protein commonly associated with the neurological damage seen in Parkinson's disease.

Continuing the wave of cutting-edge new migraine drugs reaching the American market, the U.S. Food and Drug Administration (FDA) has now approved the first oral calcitonin gene-related peptide (CGRP) antagonist for acute migraine treatment.

Two compelling new studies are building on a hypothesis suggesting age-related dementia is caused by a leaky blood-brain barrier. Experts suggest the studies are interesting but not particularly applicable to human cases of dementia.